PMID: 8939190Nov 1, 1996Paper

Effects of nedocromil sodium on inflammation and symptoms in therapeutic studies

The Journal of Allergy and Clinical Immunology
P S Creticos

Abstract

This review cites clinical evidence demonstrating that nedocromil sodium can reverse the clinical features of airway inflammation in asthma, as shown by decreased bronchial responsiveness, decreased diurnal variation in peak expiratory flow, improved baseline lung function, and a decrease in the frequency and severity of chronic symptoms. Clinical trials have also shown that nedocromil sodium has a statistically significant and clinically relevant effect on daytime and nighttime asthma symptoms within 3 days of starting treatment. On an analysis of relevant trials, the effect on asthmatic cough was significant within 24 hours. This rapid effect on symptoms, together with a reversal of the underlying airways inflammation, is a beneficial combination in the management of asthma.

References

Mar 22, 1979·The New England Journal of Medicine·W M CorraoR S Irwin
May 1, 1991·The Journal of Allergy and Clinical Immunology·R AalbersJ G de Monchy
Apr 1, 1995·The Journal of Allergy and Clinical Immunology·P CreticosS Findlay
Jul 1, 1993·The Journal of Allergy and Clinical Immunology·H J SchwartzK C Bergmann

❮ Previous
Next ❯

Citations

Nov 8, 2005·Cough·Anne B Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.